RT-59

14th International Congress
THE "NEW FRONTIERS"
OF ARRHYTHMIAS 2000

Jan. 29 - Feb. 5, 2000
Marilleva, Trento, Italy

RT-59

Atrial fibrillation ablation: radiofrequency versus ultrasound. Morphologic considerations

Saroja Bharati.
Maurice Lev Congenital Heart and Conduction System Center, The Heart Institute for Children, Hope Children’s Hospital, Christ Hospital and Medical Center, Oak Lawn, Rush Medical College, Rush University, Rush-Presbyterian-St. Luke’s Medical Center, Chicago, Finch University of Health Sciences, Chicago Medical School, North Chicago, University of Illinois at Chicago, Chicago, USA

Abstract

Today, radiofrequency catheter ablation has revolutionized the treatment of practically all types of cardiac arrhythmias in all age groups. The quality of life has been demonstrated to improve significantly following radiofrequency ablation. However, radiofrequency ablation of intractable drug resistant cardiac arrhythmias such as atrial fibrillation and flutter remain a challenge for the electrophysiologist. Therefore, a new method of localization and ablation of arrhythmic foci within the pulmonary veins was performed by means of a new ultrasound venous ablation catheter. Circumferential ablation of the pulmonary venous ostia by an ultrasound venous catheter in the chronic canine model revealed increase in fibrous tissue with total replacement of the smooth muscle fibers by connective tissue with some increase in elastic tissue. In addition, the left atrium adjacent to the targeted vein revealed mild fibrosis and occasional mild cartilage formation elsewhere in the atrium. Only one pulmonary vein demonstrated thrombosis and marked stenosis. In contrast, radiofrequency ablation of atrial fibrillation in chronic canine model revealed extensive fibrosis, chronic inflammatory cells, fat and cartilage formation. The pathological lesions following ultrasound ablation of arrhythmic foci within the pulmonary venous ostia in the chronic canine model affects mostly in the targeted area. In addition, the lesions are less severe when compared with the radiofrequency ablation suggesting the feasibility of this technique in the human.

Key Words


 

forward

CARDIOnet® - registered trade mark name
Copyright © 1996-2000 by CARDIOnet. All rights reserved.